Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Carrillo

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Mycoses|June 21, 2006
In vitro antifungal susceptibility testing of filamentous fungi with Sensititre Yeast OneA J Carrillo-Muñoz, G Quindós, M Ruesga, et al.
The Journal of Antimicrobial Chemotherapy|October 8, 1999
In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazoleA J Carrillo-Muñoz, G Quindós, C Tur, et al.
Mycoses|December 3, 2003
Performance of Bacticard Candida compared with the germ tube test for the presumptive identification of Candida albicansA J Carrillo-Muñoz, G Quindós, C D Cárdenes, et al.
Chemotherapy|December 13, 2007
Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tabletsA J Carrillo-Muñoz, G Quindós, O del Valle, et al.
International Journal of Antimicrobial Agents|June 9, 2007
In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosisA J Carrillo-Muñoz, G Giusiano, J Guarro, et al.
Journal of Chemotherapy (Florence, Italy)|April 17, 2007
Comparison of tablet and disk diffusion methods for fluconazole and voriconazole in vitro activity testing against clinical yeast isolatesA Rementeria, L O Sanchez-Vargas, M Villar, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|December 26, 2001
[Activity of itraconazole against clinical isolates of Aspergillus spp. and Fusarium spp. determined by the M38-P NCCLS method]A J Carrillo-Muñoz, G Quindós, M Ruesga, et al.
International Journal of Antimicrobial Agents|January 15, 2011
Posaconazole susceptibility of clinical yeast isolates determined by an agar diffusion and microdilution methodA J Carrillo-Muñoz, C Tur-Tur, G Quindós, et al.
Revista Iberoamericana De Micologia|March 15, 2005
[In vitro activity of a liposomal nystatin formulation (Nyotran) against Cryptococcus neoformans]R Alonso-Vargas, L González-Alvarez, M T Ruesga, et al.
Journal of Chemotherapy (Florence, Italy)|August 5, 2008
In vitro antifungal activity of sertaconazole nitrate against recent isolates of onychomycosis causative agentsA J Carrillo-Muñoz, G Quindós, O Del Valle, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Mycoses|June 21, 2006
In vitro antifungal susceptibility testing of filamentous fungi with Sensititre Yeast OneA J Carrillo-Muñoz, G Quindós, M Ruesga, et al.
The Journal of Antimicrobial Chemotherapy|October 8, 1999
In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazoleA J Carrillo-Muñoz, G Quindós, C Tur, et al.
Mycoses|December 3, 2003
Performance of Bacticard Candida compared with the germ tube test for the presumptive identification of Candida albicansA J Carrillo-Muñoz, G Quindós, C D Cárdenes, et al.
Chemotherapy|December 13, 2007
Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tabletsA J Carrillo-Muñoz, G Quindós, O del Valle, et al.
International Journal of Antimicrobial Agents|June 9, 2007
In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosisA J Carrillo-Muñoz, G Giusiano, J Guarro, et al.
Journal of Chemotherapy (Florence, Italy)|April 17, 2007
Comparison of tablet and disk diffusion methods for fluconazole and voriconazole in vitro activity testing against clinical yeast isolatesA Rementeria, L O Sanchez-Vargas, M Villar, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|December 26, 2001
[Activity of itraconazole against clinical isolates of Aspergillus spp. and Fusarium spp. determined by the M38-P NCCLS method]A J Carrillo-Muñoz, G Quindós, M Ruesga, et al.
International Journal of Antimicrobial Agents|January 15, 2011
Posaconazole susceptibility of clinical yeast isolates determined by an agar diffusion and microdilution methodA J Carrillo-Muñoz, C Tur-Tur, G Quindós, et al.
Revista Iberoamericana De Micologia|March 15, 2005
[In vitro activity of a liposomal nystatin formulation (Nyotran) against Cryptococcus neoformans]R Alonso-Vargas, L González-Alvarez, M T Ruesga, et al.
Journal of Chemotherapy (Florence, Italy)|August 5, 2008
In vitro antifungal activity of sertaconazole nitrate against recent isolates of onychomycosis causative agentsA J Carrillo-Muñoz, G Quindós, O Del Valle, et al.
Pageof 9